The high expression of these 28 genes in tumor tissue, including IFNGR1, IFNGR2, IL1A, IL1B, TLR2, TLR4, FOSL1, and CSF1, associates with a lower risk of cancer recurrence and better survival rate in BC patients (Figure 5). This evidence concerns the gene FOSL1 and neoplasm.